In G422 murine glioma models, it has been shown that PDT increases the ratio of CD4+/CD8+ lymphocytes and promotes TNF-α and IFN-γ release and promotes an anti-glioma response mediated by complement C3 and T-cells [120]. The gene discussed is CD4; the disease is glioma.